PaperProphet vs. NYSE: SAI.....tough call.  I'm going to

New Post Public Reply Private Reply Replies (0) Message Board
Rawnoc

PaperProphet vs. NYSE: SAI.....tough call.  I'm going to go with NYSE: SAI who's numbers seem to suggest under $10/barrel or under .25/gallon for diesel is possible.  NYSE: SAI has an absolutely amazing credible historical records whereas the failure of a real estate agent has a history of nothing BUT failure.

NYSE: SAI

http://postimage.org/image/y1uezgx53

PaperProphet:

PaperProphet Investing Track Record -- Please Help

Can anybody find ANY examples of actual success at all???? Here's what I found so far:

Symbol Return
TBUS(Q) -99.97%
MBHI(Q) -100.00%
COWI -99.99%
CDGT -100.00%
SORL -74.00%
CCHI -99.50%
AIDA -97.00%


(with TBUSQ at 2.98 now down -99.97% to .0008)
"Digital Recorders is one of the few companies serving that area which also has good, steady revenue and earnings growth. I suspect they will continue to do well...it's a great long-term hold."

(with MBHI(Q) at .28 now down -100% or total wipeout)
"I'm in too at $0.28. The downside to me seems that they do that $100 million+ offering at a few cents below the current price. The upside is that they reduce their offering to only taking cash when they need it for the next year or so"

(with COWI at split-adjusted hundreds of dollars per share, now down -99.99% to .0006)
"I just got a partial fill of Innova at $0.065....I think Innova has a decent shot...it seems to have good potential"

(with CDGT in the mid $.30s, now down -100% or total wipeout)
"I do think the risk/reward is good and I did start buying. I believe it's a good risk here in the mid $0.30's"

(with SORL at 7.05, now down -74%)
"$130 million market cap with great growth and $4.1 million in net income this quarter. At first glance, this seems too undervalued."

(with CCHI at $20.00, now down -99.5%)
"CCHI has $23 million in solid shareholders' equity."

(with CCHI at $10.00)
"There should still be over $40/share worth of equity and the stock is trading at $10"

(with CCHI at $6.50)
"Looks like $39.40 in equity per share"

(with CCHI at $5.00)
"It's at least close to $25/share in equity."

(with CCHI at $1.25)
"As of the last annual report, the company had over $11 million in equity and about 350,000 shares outstanding (about $30/share)."

(with AIDA from 1.19 just before a -74% steady plunge over the next year and -97% currently at .04)
"I've been slowly buying shares and got a few more today...I think Aida will be at least a three-bagger at some point within the next year"

(with AIDA at .70)
"Imagine a $0.70 stock earning $2.00 per share per year. If a dozen or so people had confidence in those numbers, the stock wouldn't be anywhere near $0.70.....I have a good number of shares--I like lower risk."

(with AIDA at .69)
"I think it's a very good potential return for the risk. The $0.50 drop may have been a little more than it deserved"

(with AIDA at .48)
"it looks like an extremely good deal based on its current business...That revenue and margin growth was amazing, though, especially for the second quarter. Had they not had those two expenses, earnings for the quarter would have been about $0.06 and the two historically good quarters are coming next...I think it's a good risk for the potential reward"

(with AIDA at .31)
"Down $0.24 to close at $0.31. Hard to say if there was any reason for the drop or not."

(with AIDA at .10)
"Aida's drop may or may not be justified...At this price, the company could buy nearly all the outstanding shares with just what they earned last quarter"
"If Aida's financials are accurate and if Aida is fair to shareholders going forward then Aida stock is the deal of the century"

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 3

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 4

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 3

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 2

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 4

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Energy Inc. Details Upcoming Financial Results Call

Updated Category News Views 123

Liberty Energy Inc. to Announce Key Financial Outcomes Liberty Energy Inc. (NYSE: LBRT) is preparing to release its financial results for the fourth quarter and full year ending December 31, 2024, just after market close on January 29, 2025. This key announcement will eagerly be anticipated by investors and market analysts alike. Conference Call to Discuss Financial...

Continue Reading
Cambridge Achieves Major Revenue Mark of Over $2 Billion

Updated Category News Views 283

Cambridge Achieves Significant Revenue Milestone Cambridge Investment Research, Inc., a notable player in financial solutions, has recently announced a groundbreaking accomplishment: surpassing $2 billion in annual revenue for the first time. This impressive feat showcases the company's remarkable growth over a short duration, doubling its revenue in just five years. A...

Continue Reading
Elon Musk's Generous Gesture: Free Starlink Terminals for Victims

Updated Category News Views 453

Elon Musk's Commitment to Supporting Wildfire Victims SpaceX CEO Elon Musk recently announced his company’s plan to provide free Starlink terminals to regions experiencing the devastating effects of wildfires. This compassionate initiative aims to support affected communities as they navigate through challenging times. Details of the Initiative In a recent post on his...

Continue Reading
Elevating Leadership at Know Labs for Innovative Solutions

Updated Category News Views 68

Elevating Leadership at Know Labs for Innovative Solutions Know Labs, Inc. (NYSE American: KNW), a pioneering entity in non-invasive diagnostic technology, has announced the addition of two significant leaders to its executive team. John Cronin is stepping into the role of Interim Chief Technology Officer, while Dominic Klyve, Ph.D., will serve as the Chief Science...

Continue Reading
Centrus Energy's New Funding Boosts Advanced Nuclear Projects

Updated Category News Views 176

Critical Funding for Advanced Nuclear Fuel Supply In a significant move towards strengthening the nuclear energy sector, Centrus Energy has announced that its subsidiary, American Centrifuge Operating, LLC, has secured an important award from the U.S. Department of Energy. This funding is dedicated to deploying cutting-edge technology and equipment aimed at converting...

Continue Reading